Frontiers in Oncology | Genitourinary Oncology

Original Research

Published on 04 Sep 2026

Development and external validation of a simple pre-biopsy risk stratification model for clinically significant prostate cancer in men with PI-RADS 3 lesions: a multicenter transperineal biopsy study

in Genitourinary Oncology

Xuhui Peng
Xinyu Yi
Shan Tang

Frontiers in Oncology

doi 10.3389/fonc.2026.1864100

611 views

Review

Published on 03 Sep 2026

Adjuvant therapy in chromophobe renal cell carcinoma: current evidence and unmet needs

in Genitourinary Oncology

Niovi Bejjani
Joseph Kattan

Frontiers in Oncology

doi 10.3389/fonc.2026.1910114

273 views

Original Research

Published on 03 Sep 2026

Performance evaluation of large language models in bladder cancer patient education Q&A: a cross-sectional study

in Genitourinary Oncology

Dian Wan
Youwen Li
Zheng Dong
Chen Dai
Jinghe Ye
Song Li
Sunlu Jiang

Frontiers in Oncology

doi 10.3389/fonc.2026.1909227

317 views

Original Research

Published on 03 Sep 2026

Factors associated with clinical research participation among Medicare beneficiaries with prostate cancer in the United States

in Genitourinary Oncology

Ryan A. Hankins
Alysha M. McGovern
Abimbola O. Williams
Virgil H. Simons
Sean P. Collins
Deepak Kumar

Frontiers in Oncology

doi 10.3389/fonc.2026.1887816

339 views

Case Report

Published on 03 Sep 2026

Case Report: Radical nephroureterectomy after toripalimab plus disitamab vedotin in biomarker-non-enriched upper tract urothelial carcinoma

in Genitourinary Oncology

Guohui Cheng
Quan Zhang
Rundong Li
Zhongze Zhou
Xiangbin Kong
Zhilong Dong

Frontiers in Oncology

doi 10.3389/fonc.2026.1857919

227 views

Case Report

Published on 03 Sep 2026

Testicular intestinal-type adenocarcinoma without an identifiable extratesticular primary site: a case report and literature review

in Genitourinary Oncology

Jinrong Tang
Heng Jiang
Xiaoke Zeng

Frontiers in Oncology

doi 10.3389/fonc.2026.1926619

318 views

Case Report

Published on 03 Sep 2026

Contrast-enhanced ultrasound features of primary renal Ewing-like undifferentiated small round cell neoplasm: a case report

in Genitourinary Oncology

Xueling Tang
Jie Xue

Frontiers in Oncology

doi 10.3389/fonc.2026.1902656

200 views

Original Research

Published on 03 Sep 2026

MRI-derived features reveal recurrence heterogeneity in VI-RADS 2 non-muscle-invasive bladder cancer

in Genitourinary Oncology

Junpeng Sun
Ziyong Wang
Maofa Yang
Zijian Tan
Hong Sun
Xusong Pang
Longguo Dai
Siting Wang
Kun Zhang
Tenglu Ma

Frontiers in Oncology

doi 10.3389/fonc.2026.1921569

788 views

Case Report

Published on 03 Sep 2026

Case Report: Solitary right thigh skin metastasis of bladder cancer misdiagnosed as erysipelas with literature review

in Genitourinary Oncology

Zhaonan Hou
Mingfeng Ji
Fang Peng
Yihao Chen
Zhiyu Liu
Zhihong Dai

Frontiers in Oncology

doi 10.3389/fonc.2026.1825362

353 views

Original Research

Accepted on 02 Sep 2026

MRI-based Habitat radiomics analysis for Predicting Clinically Significant Prostate Cancer: a retrospective dual-center study

in Genitourinary Oncology

Ze Fei Chen
Yin quan Ye
Yun Peng
Zijian Gong
Zhixuan Liu
Xiao chang Xiang
Yan liang Liao
Lianggeng Gong

Frontiers in Oncology

Original Research

Accepted on 01 Sep 2026

The deubiquitinating enzyme UCHL3 promotes bladder cancer progression and glycolysis through enhancing PKM2 protein stability

in Genitourinary Oncology

Wan Xiang
Gengsheng Shi
Yanyan Wu
Yingying Wang
Suyu Wang
Wenqin Yin
Ruirui Li

Frontiers in Oncology

130 views

Original Research

Accepted on 01 Sep 2026

Preclinical Identification of an Oxadiazole-Pyrazole Lead Targeting Prostate Cancer through Integrated Mechanistic Evaluation

in Genitourinary Oncology

Vanktesh Kumar
Pankaj Wadhwa
Shubham Kumar

Frontiers in Oncology

130 views

Review

Accepted on 01 Sep 2026

Barriers and Facilitators to Implementing Precision Oncology for Prostate Cancer in Sub-Saharan Africa: Diagnostic Infrastructure and Policy Frameworks

in Genitourinary Oncology

Charles Malisaba Posite
Raymond Atwine
Henry Wabinga
Ibe Michael Usman

Frontiers in Oncology

Mini Review

Published on 01 Sep 2026

BCG after trimodality therapy: managing non-muscle-invasive recurrence in the irradiated bladder

in Genitourinary Oncology

Nicola Fazaa
Etan Eigner
Melissa Atallah
Yuval Shafran
Gilad Amiel
Azik Hoffman

Frontiers in Oncology

doi 10.3389/fonc.2026.1953755

1,079 views

Case Report

Published on 01 Sep 2026

Trastuzumab deruxtecan treatment for HER2-low metastatic scrotal extramammary Paget’s disease with bone marrow involvement: a case report

in Genitourinary Oncology

Yi Bao
Lei Zhang
Fenfen Jiang
Juanfen Mo

Frontiers in Oncology

doi 10.3389/fonc.2026.1886979

557 views

Case Report

Published on 31 Aug 2026

Expression of nectin-4 in squamous cell carcinoma of prostate: a pilot study and case report

in Genitourinary Oncology

Xizhen Zhao
Fang Yu
Rui Zhou
Jiantao Xiao
Jianjun Fang
Tao Liu
Zhonghua Yang

Frontiers in Oncology

doi 10.3389/fonc.2026.1914312

468 views

Case Report

Published on 31 Aug 2026

Refractory thrombocytopenia induced by enzalutamide combined with docetaxel chemotherapy in a metastatic castration-resistant prostate cancer patient with bone marrow metastasis: a case report and literature review

in Genitourinary Oncology

Yong Chen
Junbo Liu

Frontiers in Oncology

doi 10.3389/fonc.2026.1863480

369 views

Original Research

Published on 31 Aug 2026

Interpretable machine-learning risk stratification at the time of diagnosis for 3-year mortality in de novo metastatic prostate cancer: development and temporal validation in SEER

in Genitourinary Oncology

Xin Wang
Guanglei Yao
Heqian Liu
Wei Ding

Frontiers in Oncology

doi 10.3389/fonc.2026.1904589

408 views

Original Research

Accepted on 30 Aug 2026

ABRAXAS1-HELQ is a candidate class-matched reference chimeric RNA and contributes to prostate cell motility through MCOLN2

in Genitourinary Oncology

Jie Chen
Huiwen Tang
Fangdong Li
Jirong Jie
Liang Si
Yiwei Wang
Samir Lalani
Wensen Xiao
Qiong Wang
Qiang Dang

Frontiers in Oncology

112 views

Original Research

Accepted on 28 Aug 2026

Reduced Nectin-4 Expression in Lymph Node Metastases of Penile Squamous Cell Carcinoma: A Paired Primary–Metastatic Analysis

in Genitourinary Oncology

Tianhao Ma
Kun Wang
Feiran Chen
Hongcheng Zhao
Chunsen Yang
Buwei Wu
Xin Yao

Frontiers in Oncology

128 views

Review

Published on 28 Aug 2026

Advances in understanding the tumor microenvironment of neuroendocrine prostate cancer

in Genitourinary Oncology

Nan Yao
Qixing Yang
Pengkang Chang
Yangcai Wang
Hao Li
Ronghua Wu
Ji Zheng
Weihua Fu

Frontiers in Oncology

doi 10.3389/fonc.2026.1928713

489 views

Original Research

Published on 28 Aug 2026

PSMA-RECAP: [177Lu]Lu-PSMA-617 retreatment in metastatic castration-resistant prostate cancer

in Genitourinary Oncology

Gokce Belge Bilgin
Cem Bilgin
Ann T. Packard
Brian J. Burkett
Elif Su Oztekin
Matthew P. Thorpe
Daniel S. Childs
Miguel Muniz
Ronen Stoff
Yalda Nikanpour

Frontiers in Oncology

doi 10.3389/fonc.2026.1831393

727 views

Case Report

Published on 27 Aug 2026

Case Report: Targeting EGFR exon 20 insertion and MTAP loss in refractory metastatic upper tract urothelial carcinoma

in Genitourinary Oncology

Karen Hoi Lam Li
Roland Ching Yu Leung
Thomas Yau
Joshua Jing Xi Li
Josephine Wing Yan Tsang
Jenny Wai Yan Lo
Gerry Gin Wai Kwok
Jeffrey Sum Lung Wong
Alvin Hoi Wai Chan
Bryan Cho Wing Li

Frontiers in Oncology

doi 10.3389/fonc.2026.1928596

595 views

Systematic Review

Accepted on 26 Aug 2026

ctDNA- and cfDNA-based liquid biopsy in bladder cancer and urothelial carcinoma: bibliometric mapping and cross-database coverage analysis, 2008-2025

in Genitourinary Oncology

Junhua Li
Chenhao Tang
Longfei Yang
Chen Song
Pan Huixiaan

Frontiers in Oncology

137 views

2,102 articles

articles

Development and external validation of a simple pre-biopsy risk stratification model for clinically significant prostate cancer in men with PI-RADS 3 lesions: a multicenter transperineal biopsy study

Adjuvant therapy in chromophobe renal cell carcinoma: current evidence and unmet needs

Performance evaluation of large language models in bladder cancer patient education Q&A: a cross-sectional study

Factors associated with clinical research participation among Medicare beneficiaries with prostate cancer in the United States

Case Report: Radical nephroureterectomy after toripalimab plus disitamab vedotin in biomarker-non-enriched upper tract urothelial carcinoma

Testicular intestinal-type adenocarcinoma without an identifiable extratesticular primary site: a case report and literature review

Contrast-enhanced ultrasound features of primary renal Ewing-like undifferentiated small round cell neoplasm: a case report

MRI-derived features reveal recurrence heterogeneity in VI-RADS 2 non-muscle-invasive bladder cancer

Case Report: Solitary right thigh skin metastasis of bladder cancer misdiagnosed as erysipelas with literature review

MRI-based Habitat radiomics analysis for Predicting Clinically Significant Prostate Cancer: a retrospective dual-center study

The deubiquitinating enzyme UCHL3 promotes bladder cancer progression and glycolysis through enhancing PKM2 protein stability

Preclinical Identification of an Oxadiazole-Pyrazole Lead Targeting Prostate Cancer through Integrated Mechanistic Evaluation

Barriers and Facilitators to Implementing Precision Oncology for Prostate Cancer in Sub-Saharan Africa: Diagnostic Infrastructure and Policy Frameworks

BCG after trimodality therapy: managing non-muscle-invasive recurrence in the irradiated bladder

Trastuzumab deruxtecan treatment for HER2-low metastatic scrotal extramammary Paget’s disease with bone marrow involvement: a case report

Expression of nectin-4 in squamous cell carcinoma of prostate: a pilot study and case report

Refractory thrombocytopenia induced by enzalutamide combined with docetaxel chemotherapy in a metastatic castration-resistant prostate cancer patient with bone marrow metastasis: a case report and literature review

Interpretable machine-learning risk stratification at the time of diagnosis for 3-year mortality in de novo metastatic prostate cancer: development and temporal validation in SEER

ABRAXAS1-HELQ is a candidate class-matched reference chimeric RNA and contributes to prostate cell motility through MCOLN2

Reduced Nectin-4 Expression in Lymph Node Metastases of Penile Squamous Cell Carcinoma: A Paired Primary–Metastatic Analysis

Advances in understanding the tumor microenvironment of neuroendocrine prostate cancer

PSMA-RECAP: [177Lu]Lu-PSMA-617 retreatment in metastatic castration-resistant prostate cancer

Case Report: Targeting EGFR exon 20 insertion and MTAP loss in refractory metastatic upper tract urothelial carcinoma

ctDNA- and cfDNA-based liquid biopsy in bladder cancer and urothelial carcinoma: bibliometric mapping and cross-database coverage analysis, 2008-2025